OneSource Specialty Pharma Ltd.

NSE: ONESOURCE | BSE: 544292 | ISIN: INE013P01021 | Industry: Pharmaceuticals
| Momentum Trap
1488.3000 -19.70 (-1.31%)
NSE Oct 05, 2026 15:31 PM
Volume: 151.3K
 

logo
OneSource Specialty Pharma Ltd.
06 Sep 2026, 12:00AM
1488.30
-1.31%
ICICI Securities Limited
We recently visited OneSource’s drug-device combination (DDC) manufacturing plant in Bangalore. OneSource is the only CDMO with generic semaglutide approvals across the G7 nations.
Number of FII/FPI investors increased from 207 to 222 in Jun 2026 qtr.
More from OneSource Specialty Pharma Ltd.
Recommended